A

Agilent Technologies, Inc.

September 24, 2026 · intraday

Rarity

1.72

Peak move

+5.69%

Float cap

$46.6B

Agilent Technologies provides application-focused solutions for life sciences, diagnostics, and applied markets, including instruments, software, services, and consumables spanning the laboratory workflow. It sells to pharmaceutical and biopharmaceutical companies, diagnostics and clinical laboratories, academic and government institutions, and applied markets such as chemicals, advanced materials, food, environmental, and forensics.

• institutional_flowSep 23 · 03:04 ET

  Andra AP fonden sold 38,200 shares of Agilent Technologies, reducing its position in the life sciences instruments maker.

  Webmarketbeat.com
• peer_disclosureSep 23

  Metir plc (UK, Microsaic Systems) updated commercial and development progress on its miniaturised mass spectrometry PFAS detection platform, including a semiconductor-industry water-monitoring programme with Puraffinity and CISM and field data at ambient temperatures up to 35°C.

  Webin.marketscreener.com
• product_launchSep 21

  Agilent launched the CE-IVD-labeled Agilent 4150 TapeStationDx and 4200 TapeStationDx systems plus TapeStationDx software for DNA/RNA quality control in clinical NGS workflows, available in the U.S., Canada and select European markets.

  Webin.marketscreener.comWebagilent.com.cnWebtradeshownews.com
• executive_remarkSep 10

  At the J.P. Morgan U.S. All Stars Conference in London on Sept. 23, 2026, Agilent CEO Padraig McDonnell and CFO Adam Elinoff discussed the Ignite transformation, reiterated a Q4 exit growth rate of 5.2%-6.2%, raised Q4 China guidance to high-single-digit growth, and said the Advanced Therapies CDMO grew 30% in fiscal Q3 with Train C capacity starting spring 2027 (75% booked).

  Webseekingalpha.comWebbusinesswire.comWebseekingalpha.comWebuk.investing.com